2023
DOI: 10.3390/plants12091870
|View full text |Cite
|
Sign up to set email alerts
|

Reports of Plant-Derived Nanoparticles for Prostate Cancer Therapy

Abstract: Plants have demonstrated potential in providing various types of phytomedicines with chemopreventive properties that can combat prostate cancer. However, despite their promising in vitro activity, the incorporation of these phytochemicals into the market as anticancer agents has been hindered by their poor bioavailability, mainly due to their inadequate aqueous solubility, chemical instability, and unsatisfactory circulation time. To overcome these drawbacks, it has been suggested that the incorporation of phy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 105 publications
0
1
0
Order By: Relevance
“…NPs represent a potentially effective treatment option for PCa in particular due to their ability to passively target solid tumors via tumor-enhanced permeability and retention effects. Moreover, owing to their small size, NPs improve the efficiency of anticancer drug loading, actively target tissues via binding to receptor-targeted molecules, and are not associated with the side effects elicited by systemic nontargeted therapy . This article discusses the roles and effects of different types of nanotherapy in remodeling the TME of PCa while also emphasizing the potential of nanotherapy to improve treatment outcomes for patients with PCa.…”
Section: Introductionmentioning
confidence: 99%
“…NPs represent a potentially effective treatment option for PCa in particular due to their ability to passively target solid tumors via tumor-enhanced permeability and retention effects. Moreover, owing to their small size, NPs improve the efficiency of anticancer drug loading, actively target tissues via binding to receptor-targeted molecules, and are not associated with the side effects elicited by systemic nontargeted therapy . This article discusses the roles and effects of different types of nanotherapy in remodeling the TME of PCa while also emphasizing the potential of nanotherapy to improve treatment outcomes for patients with PCa.…”
Section: Introductionmentioning
confidence: 99%